Nicotine replacement doesn't increase cardio risk after ACS

Nicotine replacement doesn't increase cardio risk after ACS
Use of nicotine replacement therapy does not increase the risk of adverse cardiovascular events in the first year following acute coronary syndromes, according to research published in the Oct. 1 issue of The American Journal of Cardiology.

(HealthDay)—Use of nicotine replacement therapy (NRT) does not increase the risk of adverse cardiovascular events in the first year following acute coronary syndromes (ACS), according to research published in the Oct. 1 issue of The American Journal of Cardiology.

Kevin J. Woolf, M.D., of the University of Rochester Medical Center in New York, and colleagues conducted a study involving 663 smokers with ACS, identified from a pre-existing database, who were separated into NRT (184 participants) or control (479 participants) groups based on whether they had been prescribed NRT on hospital discharge.

Of the cohort, 202 had adverse events into the first year following ACS. The researchers observed no significant difference between the groups for the one-year combined end point of death; myocardial infarction; repeat revascularization; or rehospitalization for angina, , or arrhythmia. In addition, no significant difference was found between the groups at one-year for each individual end point.

"The results of the present study suggest that NRT use after ACS was not associated with an increased risk of adverse cardiovascular events," the authors write. "These results might be particularly important in the treatment of smokers with , because the use of medication to stop smoking roughly doubles the success rates in long-term abstinence by reducing withdrawal symptoms."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

How pneumonia bacteria can compromise heart health

42 minutes ago

Bacterial pneumonia in adults carries an elevated risk for adverse cardiac events (such as heart failure, arrhythmias, and heart attacks) that contribute substantially to mortality—but how the heart is ...

An autoimmune response may contribute to hypertension

Sep 17, 2014

High blood pressure is a major risk factor for heart attack, stroke, chronic heart failure, and kidney disease. Inflammation is thought to promote the development of high blood pressure, though it is not clear what triggers ...

User comments